Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference


Werte in diesem Artikel
Aktien

59.40 EUR -0.60 EUR -1.00 %

Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2025 J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 p.m. PST.

Werbung

A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations.

About Alcon

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Connect with us on

Facebook
LinkedIn

Werbung

Aktuelle Alcon Aktie News

Werbung

Alcon Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Alcon nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
23.08.19 Alcon buy Goldman Sachs Group Inc.
22.08.19 Alcon Neutral JP Morgan Chase & Co.
14.06.19 Alcon Neutral BTIG Research
24.04.19 Alcon buy Goldman Sachs Group Inc.
18.04.19 Alcon Market Perform BMO Capital Markets